Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Clinical Pathology
Published in: BMC Clinical Pathology 1/2016

Open Access 01-12-2016 | Case report

Primary Burkitt lymphoma of the thyroid gland: case report of an exceptional type of thyroid neoplasm and review of the literature

Authors: Mohamed Allaoui, Ilias Benchafai, El Mehdi Mahtat, Safae Regragui, Adil Boudhas, Mustapha Azzakhmam, Mohammed Boukhechba, Abderrahmane Al Bouzidi, Mohamed Oukabli

Published in: BMC Clinical Pathology | Issue 1/2016

Login to get access

Abstract

Background

Primary thyroid lymphoma is an uncommon pathological entity that accounts for only 1 to 5 % of all thyroid malignancies. Primary Burkitt lymphoma of the thyroid gland is very rare. This article presents the first Moroccan case of a primary BL of the thyroid to be reported in the literature to date.

Case presentation

We describe here a case of a 70-year-old male who developed a rapidly enlarging thyroid gland with progressive symptoms of compression. Core biopsy confirmed the diagnosis of Burkitt lymphoma. The patient died of septic shock, 2 weeks after the first cycle of appropriate therapeutic chemotherapy.

Conclusions

This presentation emphasizes the importance of considering lymphoma when dealing with a thyroid mass, as its management is different from that of other thyroid pathologies, and affords an opportunity to review a very rare type of primary thyroid lymphoma.
Literature
1.
Camera A, Magri F, Fonte R, et al. Burkitt-like lymphoma infiltrating a hyperfunctioning thyroid adenoma and presenting as a hot nodule. Thyroid. 2010;20(9):1033–6.CrossRefPubMed
2.
Kalinyak JE, Kong CS, McDougall IR. Burkitt’s lymphoma presenting as a rapidly growing thyroid mass. Thyroid. 2006;16(10):1053–7.CrossRefPubMed
3.
Murphy SB. Classification, staging and end results of treatment of childhood non- Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332–9.PubMed
4.
Ribrag V, Koscielny S, Bouabdallah K, et al. Addition of rituximab improves outcome of HIV negative patients with Burkitt lymphoma treated with the LMBA protocol: results of the randomized intergroup (GRAALL-lysa) LMBA02 protocol [abstract]. Blood. 2012;120(21):Abstract 685.
5.
Derringer GA, Thompson LD, Frommelt RA, Bijwaard KE, Heffess CS, Abbondanzo SL. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol. 2000;24:623e39.CrossRef
6.
Pedersen RK, Pedersen NT. Primary non-Hodgkin’s lymphoma of the thyroid gland: a population based study. Histopathology. 1996;28(1):25–32.CrossRefPubMed
7.
Earnest LM, Cooper DS, Sciubba JJ, Tufano RP. Thyroid MALT lymphoma in patients with a compressive goiter. Head Neck. 2006;28(8):765–70.CrossRefPubMed
8.
Yang L, Wang A, Zhang Y, Mu Y. 12 cases of primary thyroid lymphoma in China. J Endocrinol Investig. 2015;38(7):739–44.CrossRef
9.
Alzouebi M, Goepel JR, Horsman JM, et al. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol. 2012;40(6):2075–80.PubMed
10.
Kandil E, Safah H, Noureldine S, et al. Burkitt-like lymphoma arising in the thyroid gland. Am J Med Sci. 2012;343(1):103–5.CrossRefPubMed
11.
Ha CS, Shadle KM, Medeiros LJ, Wilder RB, Hess MA, Cabanillas F, et al. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer. 2001;91:629e35.CrossRef
12.
Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T, Bailey S. Burkitt’s lymphoma. Lancet. 2012;379(9822):1234–44.CrossRefPubMed
13.
Jaff ES. The 2008 WHO classifi cation of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009;1:523–31.
14.
Cooper K, Gangadharan A, Arora RS, Shukla R, Pizer B. Burkitt lymphoma of thyroid gland in an adolescent. Case Rep Pediatr. 2014;2014(187467):3.
15.
Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol. 1999;26(3):316–23.PubMed
16.
Widder S, Pasieka JL. Primary thyroid lymphomas. Curr Treat Options Oncol. 2004;5:307e13.CrossRef
17.
Holm LE, Bloomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601–4.CrossRefPubMed
18.
Matsuzuka F, Miyauchi A, Katayama S, Narabayashi I, Ikeda H, Kuma K, Sugawara M. Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid. 1993;3(2):93–9.CrossRefPubMed
19.
Isaacson PG. Lymphoma of the thyroid gland. Curr Top Patyhol. 1997;91:1e14.
20.
Kossev P, Livolsi V. Lymphoid lesions of the thyroid: review in light of the revised Europeane American lymphoma classification and upcoming World Health Organization classification. Thyroid. 1999;9:1273e80.CrossRef
21.
Saxena A, Alport EC, Moshynska O, Kanthan R, Boctor MA. Clonal B cell populations in a minority of patients with Hashimoto’s thyroiditis. J Clin Pathol. 2004;57:1258e63.CrossRef
22.
23.
Sarinah B, Hisham AN. Primary lymphoma of the thyroid: diagnosis and therapeutic considerations. Asian J Surg. 2010;33(1):20–4.CrossRefPubMed
24.
Mweempwa A, Prasad J, Islam S. A rare neoplasm of the thyroid gland. N Z Med J. 2013;126(1369):75–8.PubMed
25.
Albert S. Primary Burkitt lymphoma of the thyroid. Ear Nose Throat J. 2013;92(12):E1–2.PubMed
26.
Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab. 2013;98(8):3131–8.CrossRefPubMed
27.
Ota H, Ito Y, Matsuzuka F, et al. Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid. Thyroid. 2006;16:983–7.CrossRefPubMed
28.
Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
29.
Chuang SS, Ye H, Du MQ, Lu CL, Dogan A, Hsieh PP, Huang WT, Jung YC. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B–cell lymphoma with very high proliferation index and with or without a starry–sky pattern: a comparative study with EBER and FISH. Am J Clin Pathol. 2007;128(4):558–64.CrossRefPubMed
30.
Liying Z, Lanxiang G, Guang L, Luping W, Chunwei X, Lin L, Yuwang T, Huiru F, Zhe G. Primary Burkitt’s lymphoma of the thyroid without Epstein-Barr virus infection: a case report and literature review. Oncol Lett. 2014;7(5):1519–24.
31.
Hecht JL, Aster JC. Molecular biology of Burkitt’s lymphoma. J Clin Oncol. 2000;18(21):3707–21.PubMed
32.
Queiroga EM, Gualco G, Chioato L, Harrington WJ, Araujo I, Weiss LM, Bacchi CE. Viral studies in Burkitt lymphoma: association with Epstein Barr virus but not HHV 8. Am J Clin Patho. 2008;130:186–92.CrossRef
33.
Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B–cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French pediatric oncology society of a randomized trial of 216 children. J Clin Oncol. 1991;9(1):123–32.PubMed
34.
Patte C, Auperin A, Michon J, et al. The Societe Francaise d’Oncologie pediatrique LMB89 protocol: highly eff ective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B–cell lymphomas and L3 leukemia. Blood. 2001;97:3370–79.CrossRefPubMed
35.
Metadata
Title
Primary Burkitt lymphoma of the thyroid gland: case report of an exceptional type of thyroid neoplasm and review of the literature
Authors
Mohamed Allaoui
Ilias Benchafai
El Mehdi Mahtat
Safae Regragui
Adil Boudhas
Mustapha Azzakhmam
Mohammed Boukhechba
Abderrahmane Al Bouzidi
Mohamed Oukabli
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Clinical Pathology / Issue 1/2016
Electronic ISSN: 1472-6890
DOI
https://doi.org/10.1186/s12907-016-0028-6

Other articles of this Issue 1/2016

BMC Clinical Pathology 1/2016 Go to the issue

Case report

Uterine myometrial mature teratoma presenting as a uterine mass: a review of literature

Case report

Bone metastasis from malignant phyllodes breast tumor: report of two cases

Case report

Liver cancer with concomitant TP53 and CTNNB1 mutations: a case report

Case report

Cellular angiofibroma of the vulva: a poorly known entity, a case report and literature review

Reviewer acknowledgement

BMC Clinical Pathology Reviewer Acknowledgment 2015

Case report

Chromosomal abnormality of acute promyelocytic leukemia other than PML-RARA: a case report of acute promyelocytic leukemia with del(5q)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits